Gritstone Oncology Gets $92.7M
Emeryville-based Gritstone Oncology, a cancer immunotherapy startup focused on personalized medicine for treating patients with non-small cell lung cancer and gastric cancer, said last week that it raised $92.7M in a Series B funding round. The funding was led by Lilly Asia Ventures, and also included GV (formerly Google Ventures), Trinitas Capital (Beijing) and Alexandria Venture Investments, along with Versant Ventures, The Column Group, Clarus Funds and Frazier Healthcare Partners.
posted on Monday, September 11, 2017 (Link to more information)
Related companies:
Gritstone bio, Inc.
Related stories:
> Gritstone Oncology Finds $102M In First Funding
> McKesson Buys US Oncology
> 3-V Biosciences Finds $20M
> Clovis Oncology Gets $145M
> Syapse Gets $30M For Precision Oncology Efforts
silicontap.com Home